Clinical Trial Update: Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT ) [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing immunogenicity and safety of DTaP/DT vaccine in 6-year-old children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaccine Reaction

Drugs mentioned

• DTaP/DT vaccine (diphtheria-tetanus-acellular pertussis vaccine (DTaP) or diphtheria-tetanus vaccine (DT))

Snippet

Sponsor: Zhejiang Provincial Center for Disease Control and Prevention | Conditions: Vaccine Reaction | Phase 4 | Status: UNKNOWN